首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1791390

血管支架系统市场报告：2031 年趋势、预测与竞争分析

Vascular Stent System Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年08月14日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球血管支架系统市场未来在静脉和动脉市场都可能迎来机会。预计2025年至2031年期间，全球血管支架系统市场的复合年增长率将达到6.9%。心血管疾病盛行率的上升、支架技术的进步以及人口老化是该市场发展的关键驱动因素。

Lucintel 预测，120 毫米血管将在预测期内继续占据最大市场份额，因为它旨在治疗需要长期放置支架的较大或更复杂的血管疾病。
从应用上看，以高压将血液从心臟输送到身体其他部位的动脉预计仍将占据主要地位。
按地区划分，由于创新医疗技术的广泛采用，预计北美将在预测期内实现最高成长。

这份综合报告长达150多页，提供了宝贵的见解，帮助您做出更明智的商业决策。以下是一些范例数据，其中包含一些见解：

血管支架系统市场的新趋势

由于技术进步、个人化治疗需求的不断增长以及监管环境的变化，全球血管支架系统市场正在经历转型。这些新兴趋势致力于改善患者治疗效果、提高手术效率并扩大市场进入。

生物可吸收支架：生物可吸收支架在达到预期作用后可在体内自然溶解，正日益成为主流趋势。此类支架无需永久植入，从而减少了与永久性支架系统相关的併发症。预计它们将成为未来心血管介入治疗的主要应用领域之一，尤其适用于需要临时血管支持的年轻患者。随着技术的成熟，随着对更安全、更有效治疗方案的需求日益增长，生物可吸收支架预计将获得更多市场占有率。
药物释放型支架 (DES)：药物释放型支架 (DES) 是血管支架市场的重大进展，因为它透过将药物直接输送到动脉，显着降低了血管再阻塞的风险。 DES 目前被广泛应用，因为它已被证明能够改善患者预后并最大限度地减少再次手术。随着市场的成熟，新的 DES 技术正在不断开发，以进一步增强药物传输、减少副作用并延长支架的使用寿命。这一趋势预计将推动 DES 在不同患者群体中的广泛应用。
微创技术与机器人：影像处理的微创手术正在改变血管支架市场的面貌。机器人辅助手术不仅能提供更高的精准度和准确性，还能缩短病患復原时间并降低手术风险。这些技术能够高效治疗更复杂的病例，并减少併发症。随着这项需求的持续成长，我们预期支架系统将持续创新，并融入与机器人系统和其他视觉引导技术的兼容性。
客製化和个人化支架设计：随着我们对血管疾病理解的不断加深，根据患者个体需求量身定制的支架解决方案正在兴起。个人化支架设计正在兴起，其设计会考虑动脉大小、病情进展和患者健康状况等因素。透过客製化支架以适应解剖和临床问题，可能带来更好的治疗效果。这种个人化医疗趋势预计将推动针对患者客製化支架设计的大量研究，并扩大市场规模。
支架材料的新发展：材料创新是血管支架市场的另一个大关键趋势，目前正在研究设计更俱生物相容性、更不易引发併发症的支架。生物分解性聚合物和先进合金等新材料正在开发中，以提高支架的性能和安全性。这些新材料有望降低血管再阻塞率，并提高各种血管手术中的支架效率。先进材料的使用可望提高支架置入术的长期成功率和病患满意度。

生物可吸收支架、药物释放型支架、微创技术、个人化支架设计以及材料改进等新兴趋势正在彻底改变全球血管支架系统市场。新产品和技术有望透过改善治疗效果、扩大支架治疗的可近性以及确保全球医疗保健体系的高效有效治疗，使患者受益。

血管支架系统市场的最新趋势

血管支架系统市场的最新发展反映了一种向先进、患者友好的解决方案发展的趋势，重点是透过技术创新、监管发展和产业合作开发更安全、更有效、更具成本效益的支架。

生物可吸收支架的进展：血管支架市场最重要的进展之一是生物可吸收支架，随着时间的推移而被人体吸收。这些支架为血管提供临时支撑，最大限度地减少长期併发症，并减少再次手术的需要。随着技术的成熟和临床结果的持续显现，生物可吸收支架预计将占据更大的市场份额。
新一代药物释放型支架：新一代药物释放型支架 (DES) 的研发是关键领域之一。这些支架可将药物直接输送至患处动脉，防止血管再阻塞并改善患者的长期预后。新型 DES 设计包含更有效的药物和聚合物，增强了支架减少併发症的能力，使其成为冠状动脉疾病患者的理想选择。
机器人辅助支架置入：机器人辅助支架置入术提高了支架置入术的准确性和安全性。外科医生现在可以相对精确地放置支架，同时降低併发症风险并缩短恢復时间。随着这项技术越来越普及且价格越来越亲民，该手术很可能扩展到许多高端和资源匮乏的地区。
加强监管核准：FDA 和 EMA 等监管机构正在简化创新支架系统的核准流程，使其能够更快进入市场。这种监管支持鼓励製造商开发能够改善临床疗效的新型支架技术。更快的核准加速了创新，并使先进的支架系统能够更有效率地惠及病患。
全球支架製造扩张：支架製造能力的扩张，尤其是在新兴市场，使得全球各地能够提供更多实惠的支架选择。製造商正在亚洲和拉丁美洲等地区建立生产设施，以满足日益增长的本地需求和日益激烈的竞争，同时也让更多患者能够获得高品质的支架系统。

生物可吸收支架、药物释放型支架、机器人辅助手术、法规改进以及製造业向全球市场的扩张等最新进展，正在推动血管支架系统市场的成长。这些技术创新正在提高患者护理质量，增加治疗可近性，并改变血管介入治疗的未来。

The future of the global vascular stent system market looks promising with opportunities in the veins and arteries markets. The global vascular stent system market is expected to grow with a CAGR of 6.9% from 2025 to 2031. The major drivers for this market are the rising prevalence of cardiovascular diseases, advancements in stent technology, and an aging population.

Lucintel forecasts that, within the type category, 120mm will remain the largest segment over the forecast period because it is designed to treat larger or more complex vascular conditions requiring more extended stent placements.
Within the application category, arteries will remain the larger segment due to transporting blood under higher pressure from the heart to the body.
In terms of region, North America is expected to witness the highest growth over the forecast period due to the high adoption of innovative medical technologies.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Vascular Stent System Market

The global vascular stent system market is changing with technological advancements, increased demand for personalized treatments, and regulatory changes that are reshaping the landscape. These emerging trends are focused on improving patient outcomes, enhancing the efficiency of procedures, and expanding market access.

Bioresorbable Stents: Bioresorbable stents naturally dissolve in the body after serving their purpose and are gaining traction as a leading trend. These stents obviate the need for permanent implants, which reduces complications associated with permanent stent systems. They will be one of the major players in the future of cardiovascular interventions, especially for younger patients requiring temporary vascular support. As the technology matures, bioresorbable stents will capture more market share due to the increasing demand for safer and more effective treatment options.
Drug-Eluting Stents (DES): Drug-eluting stents (DES) are the critical development in the vascular stent market as they significantly reduce the risk of restenosis, which occurs through direct medication delivery to the artery. DES use is widespread today as they have been shown to improve the outcome for the patient and minimize follow-up procedures. As the market matures, newer DES technologies are being developed to enhance drug delivery further, reduce side effects, and extend the lifespan of the stent. This trend is expected to lead to broader adoption of DES across diverse patient populations.
Minimally Invasive Techniques and Robotics: Minimally invasive procedures with the support of robotics and high-end imaging are changing the face of the vascular stent market. Robotic-assisted surgery offers better accuracy and precision while reducing recovery times for patients and surgical risks. These technologies make more complex cases treatable in an efficient manner and with fewer complications. As this demand continues to grow, stent systems are expected to see innovation that incorporates compatibility with robotic systems and further visual guidance technologies.
Customized and Personalized Stent Designs: The growth in understanding vascular diseases results in the rise of custom-designed stent solutions tailored to suit the individual patients' needs. Personalized designs of stents, taking into account factors like artery size, disease progression, and health condition of the patient, are on the rise. With this, more successful results may be seen due to customized stents for distinct anatomical and clinical issues. This trend in personalized medicine is also expected to propel a lot of research into the design of patient-specific stents, which will increase the market scope.
New Developments in Stent Materials: Material innovation is another significant trend in the vascular stent market; it is still under investigation, studying the design of biocompatible stents that would be less likely to cause complications. New materials, including biodegradable polymers and advanced alloys, are being developed to make stents better in performance and safety. The new materials have the potential to reduce restenosis rates and improve the efficiency of stents in various vascular procedures. It is expected that the use of advanced materials will enhance the long-term success and patient satisfaction of stenting procedures.

New trends, such as bioresorbable stents, drug-eluting stents, minimally invasive techniques, personalized stent designs, and improvements in the material used, are revolutionizing the vascular stent system market around the world. The new products and technologies are expected to benefit patients through improved outcomes and to increase access to stent treatment, ensuring efficient and effective treatments in healthcare delivery systems across the globe.

Recent Developments in the Vascular Stent System Market

The latest developments in the vascular stent system market reflect the trend toward advanced and patient-friendly solutions. Emphasis has been placed on developing safer, more effective, and cost-efficient stents through technological innovation, regulatory advancements, and industry partnerships.

Advancements in Bioresorbable Stents: One of the most significant advancements in the vascular stent market is bioresorbable stents, which are absorbed by the body over time. These stents provide temporary support to blood vessels, minimize long-term complications, and reduce the need for follow-up procedures. As the technology matures and clinical results continue to show promise, bioresorbable stents are expected to capture a larger share of the market.
Next-Generation Drug-Eluting Stents: One of the key areas is the development of next-generation drug-eluting stents (DES). These stents deliver medication directly to the affected arteries, thereby preventing restenosis and ensuring better long-term outcomes for patients. Newer DES designs include more effective drugs and polymers that enhance the stent's ability to reduce complications, making them a go-to option for patients with coronary artery disease.
Robotic-Assisted Stent Placement: Robotic-assisted stent placement has changed the art of delivering precision and safety in stent procedures. Surgeons can now perform the implantation of stents with relative accuracy, hence lower risks for complications and shorter recovery time. As the technology is made more accessible and affordable, this medical practice is likely to take its way into many high-end facilities and many low-resource settings.
Enhanced Regulatory Approvals: Regulatory bodies like the FDA and EMA have streamlined the approval process for innovative stent systems, allowing for quicker market entry. This regulatory support has encouraged manufacturers to develop new stent technologies that improve clinical outcomes. Faster approvals have accelerated innovation and brought advanced stent systems to patients more efficiently.
Global Expansion of Stent Manufacturing: The expansion of stent manufacturing capabilities, especially in emerging markets, has made more affordable stent options available worldwide. Manufacturers are establishing production facilities in regions like Asia and Latin America to cater to growing local demand, increasing competition, and making high-quality stent systems more accessible to a wider patient population.

Recent advancements such as bioresorbable stents, drug-eluting stents, robotic-assisted surgery, regulatory improvements, and the expansion of manufacturing into global markets are fueling the growth of the vascular stent system market. These innovations improve the quality of patient care, increase access to treatments, and transform the future of vascular interventions.

Strategic Growth Opportunities in the Vascular Stent System Market

The vascular stent system market provides several strategic growth opportunities across applications, underlined by demand from the advance in materials, technology, and patient care. The worldwide population, which is growing, and the global population continuing to age, is also enhancing demand for products like these.

Expansion in Emerging Markets: Emerging markets in Asia, Latin America, and Africa present massive growth opportunities for stent manufacturers. Improved healthcare access, rising cardiovascular diseases prevalence, and strong demand for vascular stents ensure an increase in growth in these areas. Large populations with less service access, on whom the companies are venturing to expand, also enhance the expansion of this market.
Customized Stent Solutions: Advances in personalized medicine open doors for stent manufacturers to design customized stent solutions based on the specific needs of the patient. Advances in imaging technologies and 3D printing enable the production of patient-specific stents, which leads to better results and satisfaction for treatment procedures.
Consistent with Minimally Invasive Technologies: Manufacturers will have a golden opportunity to innovate with the introduction of stent systems that integrate minimally invasive technologies, including robotic-assisted surgery and advanced imaging techniques. Such technologies provide the exact reproduction of stent placement to decrease complication rates and shorten recovery times for patients' appeal, while the healthcare providers are not left behind to have their space.
Regenerative Medicine in Stent Design: It can lead the stent market to a more open growth stage by integrating it with vascular stent technology, regenerative medicine. The use of stem cells or bioactive substances within the design may help enhance the healing of vessels further and decrease chances of complications, such as restenosis.
The drug-eluting and bioresorbable stents: The increasing demand for drug-eluting and bioresorbable stents is an excellent opportunity for manufacturers to focus on developing next-generation stents. These stents offer significant advantages over traditional ones, including improved efficacy, fewer complications, and better long-term patient outcomes.

Expansion opportunities in the vascular stent system market include emerging markets, personalized stent solutions, integration with minimally invasive technologies, regenerative medicine applications, and a focus on drug-eluting and bioresorbable stents. All these will be the factors driving the market forward and furthering patient care around the world.

Vascular Stent System Market Driver and Challenges

The majority of the factors in the vascular stent system market are technology-intensive, economic, and regulatory. Knowing these drivers and challenges is important for market players for the full exploitation of opportunities and the optimization of market pay-offs.

The factors responsible for driving the vascular stent system market include:

1. Technological Advancements: Major factors driving the market are continuous technological advancements in stent materials, design, and delivery mechanisms. Improved patient outcomes due to innovations like bioresorbable stents, drug-eluting stents, and robotic-assisted stent placement increase demand for more advanced solutions.

2. Increasing Prevalence of Cardiovascular Diseases: Rising cases of cardiovascular diseases, more importantly, in the aging population, are providing ample growth for vascular stents. As the incidence of heart disease continues to rise globally, the requirement for effective and reliable stent systems grows, opening a huge growth opportunity in the market.

3. Accessibility and Affordability Healthcare: Improved healthcare infrastructure, especially in emerging markets, is boosting demand for vascular stents. As healthcare becomes more accessible and affordable, more patients are able to undergo stenting procedures, driving market expansion.

4. Regulatory Approvals and Reimbursement Policies: Favorable regulatory policies and improved reimbursement systems are the most important drivers for market growth. Faster approval processes for new stent technologies and favorable reimbursement policies encourage manufacturers to introduce innovative products into the market, facilitating market expansion.

5. Increasing Focus on Minimally Invasive Procedures: The growing preference for minimally invasive procedures is another significant driver of market growth. With advantages such as shorter recovery times and fewer complications, minimally invasive stent placements are gaining popularity, contributing to the overall demand for advanced stent systems.

Challenges in the vascular stent system market are:

1. High Production Costs: The high cost of manufacturing advanced stents, particularly drug-eluting and bioresorbable stents, poses a challenge for market growth. These high production costs can limit the affordability and availability of cutting-edge stent technologies, especially in lower-income regions.

2. Regulatory Hurdles: Despite positive trends, there are challenges associated with the intricate regulatory environment across regions. The regulatory bodies demand high safety, efficacy, and quality standards, which delay the product development process and entry into the market for stent manufacturers.

3. Risk of Restenosis and Complications: Although there have been great improvements in stent technology, restenosis (re-narrowing of arteries) and other complications, such as thrombosis, remain risks associated with stent use. These challenges require ongoing innovation to develop safer, more effective stent systems.

Technological advancement in the vascular stent system is foremost, followed by an increased occurrence of cardiovascular diseases, improved health access, and favorable regulations. The major challenges that face the market are mainly production cost, regulatory hurdles, and the risk of restenosis.

List of Vascular Stent System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, vascular stent system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vascular stent system companies profiled in this report include-

Boston Scientific
Koninklijke Philips NV
Cook Medical
Bentley Innomed
Vesper Medical
Cordis
Abbott

Vascular Stent System Market by Segment

The study includes a forecast for the global vascular stent system market by type, application, and region.

Vascular Stent System Market by Type [Value from 2019 to 2031]:

60Mm
80Mm
100Mm
120Mm
Others

Vascular Stent System Market by Application [Value from 2019 to 2031]:

Veins
Arteries

Vascular Stent System Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Vascular Stent System Market

The global vascular stent system market has grown significantly in the last few years due to technological advancements, increasing prevalence of vascular diseases, and rising awareness about minimally invasive procedures. As medical professionals and companies focus on improving patient outcomes, innovation in stent materials, design, and delivery methods has been pivotal. The United States, China, Germany, India, and Japan are the key markets that are progressing with significant investment in research and development, along with improvements in regulations and increased healthcare infrastructure.

United States: The vascular stent system market in the United States is growing rapidly due to advanced bioresorbable stents, which can be used temporarily to remove obstructions in blood vessels. There are various new-generation drug-eluting stents (DES) approved by the FDA, which release medication for preventing restenosis, or re-narrowing of arteries. The incidence of cardiovascular diseases is also rising, and healthcare infrastructure is improving along with reimbursement policies. In addition, the use of robotic-assisted surgeries and advanced imaging technologies has made stent placement more precise and minimally invasive.
China: The vascular stent system market in China is growing rapidly because of the increasing incidence of cardiovascular diseases in the country and improvements in healthcare delivery. Local manufacturers are increasingly producing affordable, high-quality stents to cater to both domestic and international markets. Chinese regulators have streamlined approval processes for medical devices, encouraging innovation and entry into the market. There is a growing need for advanced stent technologies, including bioresorbable and drug-eluting stents, due to the fact that Chinese physicians are now emphasizing patient outcomes by developing individualized treatment plans. Moreover, rapid modernization in China's healthcare system will further expand these technologies.
Germany: Germany is one of the leaders in medical technology. The country has experienced great improvements in the vascular stent system market. Drug-eluting and bioresorbable stents are among the leading products, with the leading players investing much in R&D to enhance stent performance and minimize complications. The German market benefits from the strict regulatory standards that ensure high-quality stent systems for patients. Widespread provisions under Germany's healthcare system for vascular interventions help make stent technologies more accessible. Integration of advanced imaging and robotic systems into surgery has helped the precision and efficiency of stent placement.
India: The Indian vascular stent system market is burgeoning with rapid growth attributed to the increasing burden of cardiovascular diseases and widespread awareness of the benefits of stenting procedures. Through government initiatives and foreign investment, India has developed a competitive market for affordable stents catering to both domestic and international needs. Indian manufacturers are adopting global standards, producing high-quality stents, including drug-eluting and bioresorbable, at lower costs. In addition, improvements in the healthcare infrastructure and access to advanced technologies also increase vascular interventions within a larger population in this country.
Japan: Vascular stent technology is one of the leaders in Japan, with thorough and consistent research and development to make these stent systems even safer and more effective. In this market, there has been massive demand for high-quality drug-eluting stents that prevent the re-narrowing of arteries after stent placement. Bioresorbable stents are another development being invested in Japan and are expected to be a big market driver. Advanced imaging techniques by Japanese healthcare providers are also utilized for finer accuracy of stent placement. The country's elderly population has been contributing to the increasing demand for efficient vascular interventions and stenting solutions.

Features of the Global Vascular Stent System Market

Market Size Estimates: Vascular stent system market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Vascular stent system market size by type, application, and region in terms of value ($B).
Regional Analysis: Vascular stent system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the vascular stent system market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the vascular stent system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the vascular stent system market by type (60mm, 80mm, 100mm, 120mm, and others), application (veins and arteries), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Vascular Stent System Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 60 mm: Trends and Forecast (2019-2031)
4.4 80 mm: Trends and Forecast (2019-2031)
4.5 100 mm: Trends and Forecast (2019-2031)
4.6 120 mm: Trends and Forecast (2019-2031)
4.7 Others: Trends and Forecast (2019-2031)

5. Global Vascular Stent System Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Veins: Trends and Forecast (2019-2031)
5.4 Arteries: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Vascular Stent System Market by Region

7. North American Vascular Stent System Market

7.1 Overview
7.2 North American Vascular Stent System Market by Type
7.3 North American Vascular Stent System Market by Application
7.4 United States Vascular Stent System Market
7.5 Mexican Vascular Stent System Market
7.6 Canadian Vascular Stent System Market

8. European Vascular Stent System Market

8.1 Overview
8.2 European Vascular Stent System Market by Type
8.3 European Vascular Stent System Market by Application
8.4 German Vascular Stent System Market
8.5 French Vascular Stent System Market
8.6 Spanish Vascular Stent System Market
8.7 Italian Vascular Stent System Market
8.8 United Kingdom Vascular Stent System Market

9. APAC Vascular Stent System Market

9.1 Overview
9.2 APAC Vascular Stent System Market by Type
9.3 APAC Vascular Stent System Market by Application
9.4 Japanese Vascular Stent System Market
9.5 Indian Vascular Stent System Market
9.6 Chinese Vascular Stent System Market
9.7 South Korean Vascular Stent System Market
9.8 Indonesian Vascular Stent System Market

10. ROW Vascular Stent System Market

10.1 Overview
10.2 ROW Vascular Stent System Market by Type
10.3 ROW Vascular Stent System Market by Application
10.4 Middle Eastern Vascular Stent System Market
10.5 South American Vascular Stent System Market
10.6 African Vascular Stent System Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Vascular Stent System Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Boston Scientific
- Company Overview
- Vascular Stent System Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 Koninklijke Philips NV
- Company Overview
- Vascular Stent System Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Cook Medical
- Company Overview
- Vascular Stent System Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Bentley Innomed
- Company Overview
- Vascular Stent System Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Vesper Medical
- Company Overview
- Vascular Stent System Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.7 Cordis
- Company Overview
- Vascular Stent System Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.8 Abbott
- Company Overview
- Vascular Stent System Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Vascular Stent System Market
Figure 2.1: Usage of Vascular Stent System Market
Figure 2.2: Classification of the Global Vascular Stent System Market
Figure 2.3: Supply Chain of the Global Vascular Stent System Market
Figure 2.4: Driver and Challenges of the Vascular Stent System Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 4.1: Global Vascular Stent System Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Vascular Stent System Market ($B) by Type
Figure 4.3: Forecast for the Global Vascular Stent System Market ($B) by Type
Figure 4.4: Trends and Forecast for 60 mm in the Global Vascular Stent System Market (2019-2031)
Figure 4.5: Trends and Forecast for 80 mm in the Global Vascular Stent System Market (2019-2031)
Figure 4.6: Trends and Forecast for 100 mm in the Global Vascular Stent System Market (2019-2031)
Figure 4.7: Trends and Forecast for 120 mm in the Global Vascular Stent System Market (2019-2031)
Figure 4.8: Trends and Forecast for Others in the Global Vascular Stent System Market (2019-2031)
Figure 5.1: Global Vascular Stent System Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Vascular Stent System Market ($B) by Application
Figure 5.3: Forecast for the Global Vascular Stent System Market ($B) by Application
Figure 5.4: Trends and Forecast for Veins in the Global Vascular Stent System Market (2019-2031)
Figure 5.5: Trends and Forecast for Arteries in the Global Vascular Stent System Market (2019-2031)
Figure 6.1: Trends of the Global Vascular Stent System Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Vascular Stent System Market ($B) by Region (2025-2031)
Figure 7.1: Trends and Forecast for the North American Vascular Stent System Market (2019-2031)
Figure 7.2: North American Vascular Stent System Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American Vascular Stent System Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American Vascular Stent System Market ($B) by Type (2025-2031)
Figure 7.5: North American Vascular Stent System Market by Application in 2019, 2024, and 2031
Figure 7.6: Trends of the North American Vascular Stent System Market ($B) by Application (2019-2024)
Figure 7.7: Forecast for the North American Vascular Stent System Market ($B) by Application (2025-2031)
Figure 7.8: Trends and Forecast for the United States Vascular Stent System Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican Vascular Stent System Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian Vascular Stent System Market ($B) (2019-2031)
Figure 8.1: Trends and Forecast for the European Vascular Stent System Market (2019-2031)
Figure 8.2: European Vascular Stent System Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European Vascular Stent System Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European Vascular Stent System Market ($B) by Type (2025-2031)
Figure 8.5: European Vascular Stent System Market by Application in 2019, 2024, and 2031
Figure 8.6: Trends of the European Vascular Stent System Market ($B) by Application (2019-2024)
Figure 8.7: Forecast for the European Vascular Stent System Market ($B) by Application (2025-2031)
Figure 8.8: Trends and Forecast for the German Vascular Stent System Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French Vascular Stent System Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish Vascular Stent System Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian Vascular Stent System Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom Vascular Stent System Market ($B) (2019-2031)
Figure 9.1: Trends and Forecast for the APAC Vascular Stent System Market (2019-2031)
Figure 9.2: APAC Vascular Stent System Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC Vascular Stent System Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC Vascular Stent System Market ($B) by Type (2025-2031)
Figure 9.5: APAC Vascular Stent System Market by Application in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC Vascular Stent System Market ($B) by Application (2019-2024)
Figure 9.7: Forecast for the APAC Vascular Stent System Market ($B) by Application (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese Vascular Stent System Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian Vascular Stent System Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese Vascular Stent System Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean Vascular Stent System Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian Vascular Stent System Market ($B) (2019-2031)
Figure 10.1: Trends and Forecast for the ROW Vascular Stent System Market (2019-2031)
Figure 10.2: ROW Vascular Stent System Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW Vascular Stent System Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW Vascular Stent System Market ($B) by Type (2025-2031)
Figure 10.5: ROW Vascular Stent System Market by Application in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW Vascular Stent System Market ($B) by Application (2019-2024)
Figure 10.7: Forecast for the ROW Vascular Stent System Market ($B) by Application (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern Vascular Stent System Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American Vascular Stent System Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African Vascular Stent System Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Vascular Stent System Market
Figure 11.2: Market Share (%) of Top Players in the Global Vascular Stent System Market (2024)
Figure 12.1: Growth Opportunities for the Global Vascular Stent System Market by Type
Figure 12.2: Growth Opportunities for the Global Vascular Stent System Market by Application
Figure 12.3: Growth Opportunities for the Global Vascular Stent System Market by Region
Figure 12.4: Emerging Trends in the Global Vascular Stent System Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Vascular Stent System Market by Type and Application
Table 1.2: Attractiveness Analysis for the Vascular Stent System Market by Region
Table 1.3: Global Vascular Stent System Market Parameters and Attributes
Table 3.1: Trends of the Global Vascular Stent System Market (2019-2024)
Table 3.2: Forecast for the Global Vascular Stent System Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Vascular Stent System Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Vascular Stent System Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Vascular Stent System Market (2025-2031)
Table 4.4: Trends of 60 mm in the Global Vascular Stent System Market (2019-2024)
Table 4.5: Forecast for 60 mm in the Global Vascular Stent System Market (2025-2031)
Table 4.6: Trends of 80 mm in the Global Vascular Stent System Market (2019-2024)
Table 4.7: Forecast for 80 mm in the Global Vascular Stent System Market (2025-2031)
Table 4.8: Trends of 100 mm in the Global Vascular Stent System Market (2019-2024)
Table 4.9: Forecast for 100 mm in the Global Vascular Stent System Market (2025-2031)
Table 4.10: Trends of 120 mm in the Global Vascular Stent System Market (2019-2024)
Table 4.11: Forecast for 120 mm in the Global Vascular Stent System Market (2025-2031)
Table 4.12: Trends of Others in the Global Vascular Stent System Market (2019-2024)
Table 4.13: Forecast for Others in the Global Vascular Stent System Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Vascular Stent System Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Vascular Stent System Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Vascular Stent System Market (2025-2031)
Table 5.4: Trends of Veins in the Global Vascular Stent System Market (2019-2024)
Table 5.5: Forecast for Veins in the Global Vascular Stent System Market (2025-2031)
Table 5.6: Trends of Arteries in the Global Vascular Stent System Market (2019-2024)
Table 5.7: Forecast for Arteries in the Global Vascular Stent System Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Vascular Stent System Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Vascular Stent System Market (2025-2031)
Table 7.1: Trends of the North American Vascular Stent System Market (2019-2024)
Table 7.2: Forecast for the North American Vascular Stent System Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Vascular Stent System Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Vascular Stent System Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Vascular Stent System Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Vascular Stent System Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Vascular Stent System Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Vascular Stent System Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Vascular Stent System Market (2019-2031)
Table 8.1: Trends of the European Vascular Stent System Market (2019-2024)
Table 8.2: Forecast for the European Vascular Stent System Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Vascular Stent System Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Vascular Stent System Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Vascular Stent System Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Vascular Stent System Market (2025-2031)
Table 8.7: Trends and Forecast for the German Vascular Stent System Market (2019-2031)
Table 8.8: Trends and Forecast for the French Vascular Stent System Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Vascular Stent System Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Vascular Stent System Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Vascular Stent System Market (2019-2031)
Table 9.1: Trends of the APAC Vascular Stent System Market (2019-2024)
Table 9.2: Forecast for the APAC Vascular Stent System Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Vascular Stent System Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Vascular Stent System Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Vascular Stent System Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Vascular Stent System Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Vascular Stent System Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Vascular Stent System Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Vascular Stent System Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Vascular Stent System Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Vascular Stent System Market (2019-2031)
Table 10.1: Trends of the ROW Vascular Stent System Market (2019-2024)
Table 10.2: Forecast for the ROW Vascular Stent System Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Vascular Stent System Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Vascular Stent System Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Vascular Stent System Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Vascular Stent System Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Vascular Stent System Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Vascular Stent System Market (2019-2031)
Table 10.9: Trends and Forecast for the African Vascular Stent System Market (2019-2031)
Table 11.1: Product Mapping of Vascular Stent System Suppliers Based on Segments
Table 11.2: Operational Integration of Vascular Stent System Manufacturers
Table 11.3: Rankings of Suppliers Based on Vascular Stent System Revenue
Table 12.1: New Product Launches by Major Vascular Stent System Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Vascular Stent System Market

02-2729-4219

+886-2-2729-4219

License/价格

血管支架系统市场报告：2031 年趋势、预测与竞争分析

Vascular Stent System Market Report: Trends, Forecast and Competitive Analysis to 2031

目录

第一章执行摘要

第二章市场概述

第三章：市场趋势与预测分析

4. 血管支架系统市场（依类型）

5. 血管支架系统市场（依应用）

第六章区域分析

7.北美血管支架系统市场

第八章欧洲血管支架系统市场

9. 亚太地区血管支架系统市场

10. 世界其他地区（ROW）血管支架系统市场

第十一章竞争分析

第十二章机会与策略分析

第十三章：价值链主要企业的公司简介

第十四章附录

3. Accessibility and Affordability Healthcare: Improved healthcare infrastructure, especially in emerging markets, is boosting demand for vascular stents. As healthcare becomes more accessible and affordable, more patients are able to undergo stenting procedures, driving market expansion.

Vascular Stent System Market by Type [Value from 2019 to 2031]:

Vascular Stent System Market by Application [Value from 2019 to 2031]:

Vascular Stent System Market by Region [Value from 2019 to 2031]:

This report answers the following 11 key questions: